Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Mobia Medical, Inc.

CIK 1489993Updated Sep 27, 2026

Name history
MicroTransponder, Inc. · through Jan 21, 2026

MOBI price & chart

Provider market data

Loading TradingView…

NASDAQ:MOBI on TradingView ↗

TradingView · Data may be delayed

About the company

We are a commercial-stage medical device company redefining stroke recovery for survivors living with life-altering motor impairments. Our Vivistim Paired Vagus Nerve Stimulation (Paired VNS) System is the first and only clinically-validated, FDA-approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. Stroke is one of the leading causes of long-term disability in the United States. While advancements in acute stroke care over the past decade have significantly reduced mortality, innovation for chronic stroke recovery has lagged, resulting in a growing number of stroke survivors living with meaningful impairments. Our breakthrough Vivistim Paired VNS System (Vivistim System) addresses this unmet need. The Vivistim System includes an implanted pulse generator and lead that deliver stimulation to the vagus nerve when activated. During treatment (Vivistim Therapy), intentional bursts of stimulation are delivered during functional movement to increase neuroplasticity and durably restore motor function. Clinical data has demonstrated that Vivistim Therapy delivers meaningful improvements in upper limb function, which can help stroke su…

424B4 · 2026-05-08 · 0001628280-26-032843

Company description from the cited filing.

Offerings

Registration 333-295160

424B4 · 2026-05-08 · 0001628280-26-032843

Terms from the governing filing for this registration; not a claim that the offering is open today.

Gross proceeds
150000000.0
Net proceeds
139500000.0
Deal price
15.0
Shares
10000000
Offering price
$15.00

Filing attachments

mobi-ex99_1.htm · 8-K · 2026-08-11

EX-99.1 2 mobi-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Mobia Medical Reports Second Quarter 2026 Financial Results Austin, Texas, August 11, 2026 - Mobia Medical, Inc. (Nasdaq: MOBI), a medical device company redefining stroke recovery for survivors living with life-altering motor impairments, today reported financial results for the quarter ended June 30, 2026. Second Quarter 2026 and Recent Highlights • Reported revenue of $13.5 million, representing 102% growth over the prior year pe…

8-K · 2026-08-11 · 0001193125-26-344666

Read attachment ↗